Eli Lilly's Insulin Price Cap Deal Collapses After Cert. Denial

By Hailey Konnath · April 16, 2024, 11:08 PM EDT

Eli Lilly & Co. and insulin buyers have called off a proposed nationwide settlement that would've capped insulin prices and been worth up to $500 million over several years, a decision...

To view the full article, register now.